The Effects of Hormone Replacement Therapy on Hemostatic Variables in Women with Angiographically Verified Coronary Artery Disease: Results from the Estrogen in Women with Atherosclerosis Study

This publication has 29 references indexed in Scilit:

• The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
  Journal of Internal Medicine, 2000
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• AN ENZYME LINKED IMMUNOSORPTION ASSAY FOR TISSUE FACTOR PATHWAY INHIBITOR
  Thrombosis Research, 1997
• D-dimer test after standardized coagulation: A new assay for global evaluation of the unstimulated fibrinolytic system
  Fibrinolysis, 1993
• The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
  BJOG: An International Journal of Obstetrics and Gynaecology, 1992
• A novel principle for assessment of stimulated fibrinolysis
  Thrombosis Research, 1991
• Chromogenic substrate assay of extrinsic pathway inhibitor (EPI)
  Blood Coagulation & Fibrinolysis, 1991
• Estrogen and coronary heart disease in women
  Published by American Medical Association (AMA) ,1991
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.
  Circulation, 1987